Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Eastern Cooperative Oncology Group Stories

2011-06-06 07:05:00

DETROIT, June 6, 2011 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute was selected the winner of the 2010 Award of Excellence in the Specialty Hospitals category by Health Care Weekly Review. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO) For the fourth consecutive year, Health Care Weekly Review has recognized Michigan's heath care institutions annually for the Award of Excellence in four categories: Full Service Hospitals; Specialty Hospitals;...

2011-06-04 00:00:03

Texas Oncology Research Showcased at American Society of Clinical Oncologists Annual Meeting Dallas, TX (PRWEB) June 03, 2011 Twenty-two Texas Oncology physicians have contributed research findings to the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, which opened June 3. The international event features the latest research breakthroughs and treatment advances from physicians around the world, attracting more than 30,000 members of the oncology community each year....

2011-05-24 08:00:00

REDWOOD CITY, Calif., May 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National Cancer Institute. The ECOG 5194 validation study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS...

2011-05-22 00:02:22

The Coalition of Cancer Cooperative Groups today released a set of guiding principles for the successful overhaul of the National Cancer Institute (NCI) sponsored Clinical Trials Cooperative Group Program. Prepared by the cooperative group chairs (the Coalition Board), the principles are aimed at ensuring that upcoming changes to the federal funding guidelines under which they operate lead to a strengthening of group-generated science that improves the outcomes for patients with cancer....

2011-05-21 00:01:25

The Coalition of Cancer Cooperative Groups today released a set of guiding principles for the successful overhaul of the National Cancer Institute (NCI) sponsored Clinical Trials Cooperative Group Program. Prepared by the cooperative group chairs (the Coalition Board), the principles are aimed at ensuring that upcoming changes to the federal funding guidelines under which they operate lead to a strengthening of group-generated science that improves the outcomes for patients with cancer....

2011-05-02 15:01:00

PLAINSBORO, N.J., May 2, 2011 /PRNewswire/ -- Michael J. Hennessy & Associates, through its medical education company, ArcMesa Educators, has acquired Physicians' Education Resource (PER), a continuing medical education company that is an industry leader in producing high-quality, first-rate oncology and hematology meetings and conferences. With the merger, PER brings its website, cancerlearning.com, the rights to all of their legacy medical meetings and conferences, a robust e-mail...

2011-03-18 14:52:00

PHILADELPHIA, March 18, 2011 /PRNewswire-USNewswire/ -- The American College of Radiology's Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG), National Cancer Institute (NCI) Clinical Trials Cooperative Group members, today announced their intent to merge their clinical cancer research programs. The groups plan to form an alliance that combines their complementary strengths. The new organization will include three areas of research emphasis: early detection and...

2011-01-05 12:00:00

HINSDALE, Ill. and THE WOODLANDS, Texas, Jan. 5, 2011 /PRNewswire/ -- Hinsdale Hematology-Oncology Associates (HHOA), and US Oncology, Inc., a leading integrated oncology company, today announced a new collaboration in Illinois to expand patient access to high-quality, evidence-based cancer care through the United Network of US Oncology. (Logo: http://photos.prnewswire.com/prnh/20100517/DA06089LOGO) Cancer is not a single diagnosis; it is a host of various diseases. Hinsdale...

2010-12-11 09:00:00

THE WOODLANDS, Texas, Dec. 11, 2010 /PRNewswire/ -- Stephen Jones, M.D., medical director for US Oncology Research, co-chair of the US Oncology Breast Cancer Research Committee, and physician at Texas Oncology-Dallas, participated in the TEAM (Tamoxifen Exemestane Adjuvant Multinational) study that included nearly 10,000 patients over a five-year period. More than 2,000 of the nearly 10,000 patients studied were treated within the US Oncology system. Dr. Jones presented the compelling...

2010-12-11 00:30:30

Combination given to AML, MDS patients who have second disease and no options A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status - a measure of disease progression - researchers reported this week at the 52nd American Society of Hematology Annual Meeting. "Our findings suggest current eligibility standards that...